Nano vesicular topical drug delivery system: Types, structural components, preparation techniques, and characterizations

Nano vesicles, one of several existing nanoscale drug delivery systems, offer extremely promising new ways to develop treatments for degenerative diseases, cancer, and inflammation. The primary goals in developing nanocarriers are to control particle size, surface characteristics, and drug release to achieve specific objectives. Therefore, it is crucial to accurately characterize nanocarriers to effectively regulate their intended behavior both in clinical settings and in the body. Nanocarriers are characterized by their size, structure, and charged state, which are determined by sophisticated microscopic methods such as scanning electron microscopy, transmission electron microscopy, and atomic force microscopy. Electron microscopy is used to evaluate the surface morphology and size of particles, while dynamic light scattering and photon correlation spectroscopy are used to estimate particle size and size distribution. Colloidal stability is determined by zeta potential, which is an indirect measure of surface charge, and differential scanning calorimetry is used to characterize particles and drug interactions.

Authors

Institutions

Publication Details

Journal
Journal of emergency medicine, trauma & acute care
Published
2024-11-28
DOI
https://doi.org/10.5339/jemtac.2024.absc.16
Citations
1
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.21
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nano vesicular topical drug delivery system: Types, structural components, preparation techniques, and characterizations

Nawal A. Rajab, M. Hasan
1 citations
Journal of emergency medicine, trauma & acute care
Advancements in Transdermal Drug Delivery
0.21
article

Nano vesicular topical drug delivery system: Types, structural components, preparation techniques, and characterizations

Nawal A. Rajab, M. Hasan
article en
1 citations

Abstract

Nano vesicles, one of several existing nanoscale drug delivery systems, offer extremely promising new ways to develop treatments for degenerative diseases, cancer, and inflammation. The primary goals in developing nanocarriers are to control particle size, surface characteristics, and drug release to achieve specific objectives. Therefore, it is crucial to accurately characterize nanocarriers to effectively regulate their intended behavior both in clinical settings and in the body. Nanocarriers are characterized by their size, structure, and charged state, which are determined by sophisticated microscopic methods such as scanning electron microscopy, transmission electron microscopy, and atomic force microscopy. Electron microscopy is used to evaluate the surface morphology and size of particles, while dynamic light scattering and photon correlation spectroscopy are used to estimate particle size and size distribution. Colloidal stability is determined by zeta potential, which is an indirect measure of surface charge, and differential scanning calorimetry is used to characterize particles and drug interactions.

Journal of emergency medicine, trauma & acute careVol. 2024(6)
University of Baghdad (IQ), Baghdad Medical City (IQ), Ministry of Health (IQ)
Good health and well-being
Openalex Percentile: Top 47%
Advancements in Transdermal Drug Delivery
0.21
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.